- 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
-
Hur KY, Moon MK, Park JS, Kim SK, Lee SH, Yun JS, Baek JH, Noh J, Lee BW, Oh TJ, Chon S, Yang YS, Son JW, Choi JH, Song KH, Kim NH, Kim SY, Kim JW, Rhee SY, Lee YB, Jin SM, Kim JH, Kim CH, Kim DJ, Chun S, Rhee EJ, Kim HM, Kim HJ, Jee D, Kim JH, Choi WS, Lee EY, Yoon KH, Ko SH, Committee of Clinical Practice Guidelines, Korean Diabetes Association
- KMID: 2518889
- Diabetes Metab J.
- 2021 Jul;45(4):461-481.
- doi: 10.4093/dmj.2021.0156
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association (KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the seventh edition... -
- CITED
-
- Close
- SHARE
-
- Close
- 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea
-
Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, Kim B, Kim SJ, Kim YH, Kim JH, Kim JH, Kim EM, Nam GE, Park JY, Son JW, Shin YA, Shin HJ, Oh TJ, Lee H, Jeon EJ, Chung S, Hong YH, Kim CH, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
- KMID: 2517327
- J Obes Metab Syndr.
- 2021 Jun;30(2):81-92.
- doi: 10.7570/jomes21022
Obesity is a prevalent and complex disease. The prevalence of obesity in Korea increased from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being 23.8%... -
- CITED
-
- Close
- SHARE
-
- Close
- Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
-
Moon SS, Kim CH, Kang SM, Kim ES, Oh TJ, Yun JS, Cho HC, Kim DJ, Park TS
- KMID: 2516349
- Diabetes Metab J.
- 2021 May;45(3):459-460.
- doi: 10.4093/dmj.2021.0084
-
- CITED
-
- Close
- SHARE
-
- Close
- Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015)
-
Moon SS, Kim CH, Kang SM, Kim ES, Oh TJ, Yun JS, Cho HC, Kim DJ, Park TS
- KMID: 2514080
- Diabetes Metab J.
- 2021 Jan;45(1):115-119.
- doi: 10.4093/dmj.2020.0120
This report presents the status of diabetic neuropathy (DN) in Korea as determined using a National Health Insurance ServiceNational Sample Cohort (NHIS-NSC). Annual prevalences of DN were estimated by age... -
- CITED
-
- Close
- SHARE
-
- Close
- Adjustment of Insulin Therapy: New Insights from Continuous Glucose Monitoring
-
Oh TJ
- KMID: 2511884
- J Korean Diabetes.
- 2020 Dec;21(4):191-196.
- doi: 10.4093/jkd.2020.21.4.191
Diabetes management technology has advanced dramatically in recent decades, particularly real time continuous glucose monitoring (rtCGM) systems. A recent meta-analysis showed that rtCGM can reduce HbA1c by around 0.3% compared... -
- CITED
-
- Close
- SHARE
-
- Close
- Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide-Cohort Study (Diabetes Metab J 2020;44:737-46)
-
Kim K, Oh TJ
- KMID: 2513058
- Diabetes Metab J.
- 2020 Dec;44(6):938-939.
- doi: 10.4093/dmj.2020.0236
-
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Long-term Sodium-glucose Cotransporter 2 Inhibitor Treatment on Renal Function in the Patients with Type 2 Diabetes
-
Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY, The Committee of Clinical Practice Guideline, Korean Diabetes Association, and Committee of the Cooperative Studies, Korean Society of Nephrology
- KMID: 2507893
- Korean J Med.
- 2020 Oct;95(5):349-353.
- doi: 10.3904/kjm.2020.95.5.349
-
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Long-Term Sodium-Glucose Cotransporter 2 Inhibitor Treatment on Renal Function in Patients with Type 2 Diabetes
-
Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
- KMID: 2507040
- J Korean Diabetes.
- 2020 Sep;21(3):105-115.
- doi: 10.4093/jkd.2020.21.3.105
Chronic kidney disease commonly develops in patients with type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the... -
- CITED
-
- Close
- SHARE
-
- Close
- Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement
-
Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Lee DW, Moon MK, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
- KMID: 2507088
- Kidney Res Clin Pract.
- 2020 Sep;39(3):269-283.
- doi: 10.23876/j.krcp.20.132
Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
-
Oh TJ, Moon JY, Hur KY, Ko SH, Kim HJ, Kim T, Lee DW, Moon MK, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
- KMID: 2513009
- Diabetes Metab J.
- 2020 Aug;44(4):489-497.
- doi: 10.4093/dmj.2020.0172
Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Long-term Sodium-glucose Cotransporter 2 Inhibitor Treatment on Renal Function in the Patients with Type 2 Diabetes
-
Baek JH, Oh TJ, Moon JY, Kim T, Ko SH, Moon MK, Kim HJ, Lee DW, Hur KY
- KMID: 2504979
- Korean J Med.
- 2020 Aug;95(4):236-243.
- doi: 10.3904/kjm.2020.95.4.236
Chronic kidney disease is developed commonly in type 2 diabetes mellitus (T2DM) and is the most common cause of end-stage renal disease and related cardiovascular complications. Meanwhile, despite the current... -
- CITED
-
- Close
- SHARE
-
- Close
- Gestational Diabetes Mellitus: Diagnosis and Glycemic Control
-
Oh TJ, Jang HC
- KMID: 2503962
- J Korean Diabetes.
- 2020 Jun;21(2):69-74.
- doi: 10.4093/jkd.2020.21.2.69
Gestational diabetes mellitus (GDM) is a major medical complication of pregnancy, and it is related with poor perinatal outcomes and long-term risk of type 2 diabetes. Therefore, adequate diagnosis and... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Long-Term Pharmacotherapies for the Management of Obesity
-
Kim BY, Kang SM, Kang JH, Kim KK, Kim B, Kim SJ, Kim YH, Kim JH, Kim JH, Nam GE, Park JY, Son JW, Shin HJ, Oh TJ, Lee H, Jeon EJ, Chung S, Hong YH, Kim CH, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
- KMID: 2503838
- J Obes Metab Syndr.
- 2020 Jun;29(2):99-109.
- doi: 10.7570/jomes20010
Obesity is a serious and growing worldwide health challenge associated with type 2 diabetes mellitus, cardiovascular disease, osteoarthritis, some cancers, sleep apnea, asthma, and nonalcoholic fatty liver. The Korean Society... -
- CITED
-
- Close
- SHARE
-
- Close
- Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
-
Oh TJ, Song Y, Moon JH, Choi SH, Jang HC
- KMID: 2470652
- Ann Geriatr Med Res.
- 2019 Dec;23(4):170-175.
- doi: 10.4235/agmr.19.0039
BACKGROUND: Diabetic peripheral neuropathy (DPN) is prevalent in patients with type 2 diabetes, and its prevalence increases with age. A previous study demonstrated the association between DPN and muscle dysfunction;... -
- CITED
-
- Close
- SHARE
-
- Close
- Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
-
Jang HN, Yang YS, Lee SO, Oh TJ, Koo BK, Jung HS
- KMID: 2466257
- Endocrinol Metab.
- 2019 Dec;34(4):382-389.
- doi: 10.3803/EnM.2019.34.4.382
BACKGROUND: Conflicting results have been reported on the efficacy of insulin degludec/insulin aspart (IDegAsp) compared to basal insulin in type 2 diabetes. We investigated the effects of changing basal insulin... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Anti-Obesity Medication in Prevention of Diabetes and Its Complications
-
Oh TJ
- KMID: 2459810
- J Obes Metab Syndr.
- 2019 Sep;28(3):158-166.
- doi: 10.7570/jomes.2019.28.3.158
Diabetes is prevalent in obese population, and obesity management is the first step in preventing diabetes. Traditionally, lifestyle modification including reduced-calorie diet, physical activity, and behavior intervention is the core... -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86)
-
Oh TJ, Choi SH
- KMID: 2455678
- Diabetes Metab J.
- 2019 Aug;43(4):547-548.
- doi: 10.4093/dmj.2019.0148
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Body Fat and Diabetic Peripheral Neuropathy in Middle-Aged Adults with Type 2 Diabetes Mellitus: A Preliminary Report
-
Oh TJ, Lee JE, Choi SH, Jang HC
- KMID: 2459823
- J Obes Metab Syndr.
- 2019 Jun;28(2):112-117.
- doi: 10.7570/jomes.2019.28.2.112
BACKGROUND: Previous epidemiologic studies showed that obesity increased the risk of diabetic peripheral neuropathy (DPN). However, there is very limited data about the impact of body fat measured by body... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Glucose Tolerance Testing Allows Better Prediction of Diabetes in Women with a History of Gestational Diabetes Mellitus
-
Oh TJ, Kim YG, Kang S, Moon JH, Kwak SH, Choi SH, Lim S, Park KS, Jang HC, Hong JS, Cho NH
- KMID: 2454061
- Diabetes Metab J.
- 2019 Jun;43(3):342-349.
- doi: 10.4093/dmj.2018.0086
BACKGROUND: We aimed to identify the postpartum metabolic factors that were associated with the development of diabetes in women with a history of gestational diabetes mellitus (GDM). In addition, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
-
Oh TJ, Yu JM, Min KW, Son HS, Lee MK, Yoon KH, Song YD, Park JY, Jeong IK, Cha BS, Kim YS, Baik SH, Kim IJ, Kim DM, Kim SR, Lee KW, Park JH, Lee IK, Park TS, Choi SH, Park SW
- KMID: 2454057
- Diabetes Metab J.
- 2019 Jun;43(3):276-286.
- doi: 10.4093/dmj.2018.0051
BACKGROUND: Combination of metformin to reduce the fasting plasma glucose level and an α-glucosidase inhibitor to decrease the postprandial glucose level is expected to generate a complementary effect. We compared... -
- CITED
-
- Close
- SHARE
-
- Close
